Biotech firm Odyssey raises $279 million in upsized US IPO May 8, 2026 by wealthalpha Other news Biotech firm Odyssey raises $279 million in upsized US IPO Source link Previous News CoreWeave signals higher capex as component costs rise, shares fall Next News From Gift Nifty, US-Iran war to Trump tariffs: 8 key things that changed for Indian stock market overnight wealthalpha
Leave A Comment